Alerting Nurses to Late Effects of Pediatric Hodgkin Lymphoma Treatment
“As of January 2010, there were an estimated 379,112 survivors of childhood and adolescent cancers, of whom 35,253 (9.3%) had been treated for Hodgkin lymphoma,” according the American Cancer Society—as summarized in “Cardiotoxicity and Breast Cancer as Late Effects of Pediatric Hodgkin Lympoma (HL) Treatment,” a CE feature in the April issue of AJN.
Author Joanne Lee Candela, an adult NP in the survivorship program at the Memorial Sloan Kettering Cancer Center in New York City, hopes to raise awareness among all nurses of “residual risks associated with the various HL treatments, thereby promoting appropriate screening and, as needed, referral for specialty care.” The below table, from the article, depicts selected potential late effects of Hodgkin lymphoma treatment. Click to enlarge.
The article points out that “two of the most prevalent and life-threatening late effects are female breast cancer, secondary to chest radiation as well as to any underlying genetic tendencies, and cardiotoxicity and its sequelae, which are related to chest radiation that encompasses the heart and to the anthracycline component of chemotherapy.” […]



